San Marcos University
Lima, Peru
NCT Number: NCT01296958
The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Lima, Peru
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single oral dose of niclosamide determined by weight (dose: 11 to 34kg receive 1 gram, 35 to 50kg receive 1.5 grams, over 50kg receive 2 grams)
Education about prevention of Taenia solium infection provided in a single short (20 minute) interaction with the participant. Education was verbal with visual aids.
Time frame: Every 4 months
Time frame: 16 months
Oregon Health and Science University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001205
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03808597
Actinomycetales Infections, Bacterial Infections
Dar es Salaam, Dar, Tanzania
View Trial DetailsNCT02234570
Central Nervous System Diseases, Central Nervous System Helminthiasis
Iowa City, Iowa, United States
View Trial DetailsNCT00526916
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial Details